₹2,800.00 ₹2,000.00
Sorafenib is an oral targeted kinase inhibitor used to treat advanced renal cell carcinoma (kidney cancer), unresectable hepatocellular carcinoma (liver cancer), and radioactive iodine-resistant differentiated thyroid cancer.
How to Take It
Common Side Effects
Patients taking sorafenib may experience several side effects. Common ones include:
Sorafenib is an oral targeted kinase inhibitor used to treat advanced renal cell carcinoma (kidney cancer), unresectable hepatocellular carcinoma (liver cancer), and radioactive iodine-resistant differentiated thyroid cancer.
Medical Uses & Mechanism
Sorafenib is classified as an antiangiogenic and antineoplastic (cancer) agent. It targets multiple intracellular and cell-surface kinases—including VEGFR, PDGFR, and RAF kinases. By interrupting these signals, the drug stops or slows the division of cancer cells and starves the tumor by cutting off its blood supply.
Reviews
There are no reviews yet.